The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly ...

An analysis of the genetic activity of brain cells in individuals who have died with Alzheimer's disease has revealed the ...

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...

New details have emerged into how Alzheimer’s disease affects the brain. Researchers have identified cellular changes in the ...

As our family members age, we worry. We worry about their physical health and potential cognitive declines. If you are ...

Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a ...

Researchers at the Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk ...

Researchers have identified a key mechanism in the development of Alzheimer's disease involving the growth and pause of ...

New study uncovers how advanced brain age, even in cognitively healthy adults, signals a higher risk of Alzheimer's disease ...